1. Ciprofloxacin (PO and IV) Spectrum: best gram negative coverage of FQs, but virtually no gram positive coverage. Lacks good anaerobic coverage. 2.
ciprofloxacin), and anaerobic coverage (clindamycin or metronidazole). Dual antibiotic therapy is recommended for all necrotizing soft
Would not recommend its use in isolation against infections. Moxifloxacinhas some anaerobic coverage while levofloxacin and ciprofloxacin
Ciprofloxacin. No activity in vitro vs. B. fragilis. Clindamycin. This Usually unnecessary to offer empiric double-coverage for anaerobic
Moxifloxacinhas some anaerobic coverage while levofloxacin and ciprofloxacin do not. Metronidazole – no longer the 1st choice for C.diff
Patients with infections resistant or likely to be resistant to other therapies. Ciprofloxacin. CIPRO, g Coverage: most anaerobes, including anaerobic
discussed above, ciprofloxacin has vari¬ able activity against M pneumoniae and is not recommended for this organ¬ ism. The poor anaerobic coverage ofcip¬.
Would not recommend its use in isolation against infections. Moxifloxacinhas some anaerobic coverage while levofloxacin and ciprofloxacin
Cipro = Ciprofloxacin; Pip-Tazo = Piperacillin Routine addition of anaerobic coverage for suspected aspiration pneumonia is not recommended unless.
Comments